Lung cancer remains the leading cause of cancer-related deaths in the United States, but new advances in early detection are ...

bioAffinity Technologies (NASDAQ:BIAF) announced on March 10, 2026, the launch of a large longitudinal clinical study involving 2,000 patients to evaluate the performance of its CyPath® Lung ...

CAT scans detecting cancer is nothing new. But now, doctors are using artificial intelligence to spot cancer even sooner.“I'm here three years later because I did find out and because I did finally ...

Lung cancer symptoms are often non-specific, leading to late detection and misattribution to less severe conditions. The GO2 for Lung Cancer provides resources, policy advocacy, and access to clinical ...

PARIS--(BUSINESS WIRE)--Sensome, the pioneer of microsensing technology for real-time, intra-operative tissue analysis, today announced positive results from its first-in-human INSPECT study ...

Methods We conducted a cost-effectiveness analysis in the Yorkshire Lung Screening Trial (YLST) population comparing three ...

A new light-based sensor can spot incredibly tiny amounts of cancer biomarkers in blood, raising the possibility of earlier and simpler cancer detection. The technology merges DNA nanotechnology, ...